Pharmacy Technician Pulse

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

keyword disease-prevention

What HCPs think about medical tweetorials

pharmaphorum

OCTOBER 21, 2021

Specialists in disease areas are sometimes seen sharing tweetorials discussing studies of new treatments. Infectious disease doctor Abraar Karan posted a 13-post tweetorial in mid-March 2020, commenting on a Lancet article that examined early learnings from Wuhan. This kind of thread often engages fellow specialists or even patients.

Communication

Prominent Reasons Behind The Failure Of NAMPT inhibitors And Key Strategies Adopted By Developers To Overcome Such Challenges

Roots Analysis

NOVEMBER 3, 2023

Challenges Faced by NAMPT Inhibitors NAMPT inhibitors have emerged as a promising target for the development of therapies against a range of disease indications, especially, the different forms of cancers. Additionally, NAMPT inhibitors can have off-target effects, which can lead to toxicity and adverse side effects.

FDA

What HCPs think about medical tweetorials

Prominent Reasons Behind The Failure Of NAMPT inhibitors And Key Strategies Adopted By Developers To Overcome Such Challenges

Stay Connected